An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Epizyme to Participate in Upcoming Healthcare Conferences in March
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Epizyme (NASDAQ: EPZM), a biopharmaceutical company, announced participation in two investor conferences in March. Shefali Agarwal, Chief Medical Officer, will join the Cowen 42nd Annual Health Care Conference on March 8, 2022, at 9:10 am EST for a panel discussion. Grant Bogle, CEO, will host a fireside chat at the Barclays Global Healthcare Conference on March 15, 2022, at 2:05 pm EST. Live webcasts will be available on the company's website and archived for 60 days.
Positive
None.
Negative
None.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Epizyme, (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering transformative therapies against novel epigenetic targets, today announced its participation in two investor conferences in March.
Cowen 42nd Annual Health Care Conference Shefali Agarwal, Chief Medical Officer, will participate in the Cowen 42nd Annual Health Care Conference as part of the Targeted Oncology panel.
Tuesday, March 8, at 9:10am EST
Barclays Global Healthcare Conference Grant Bogle, Chief Executive Officer, will participate in a fireside chat at the Barclays Global Healthcare Conference.
Tuesday, March 15, 2022, at 2:05pm EST
Live webcasts of the presentations will be available under the investor section of the Company’s website at www.epizyme.com, and will be archived for 60 days following the event.
About Epizyme, Inc.
Epizyme, Inc. is a fully integrated, commercial-stage biopharmaceutical company committed to its mission of rewriting treatment for cancer through novel epigenetic medicines. The Company is focused on creating medicines that are targeted at specific causes of diseases, that are orally administered, tolerable, easy to take and based on a deep understanding of the patients that may benefit from them. The Company aspires to change the standard-of-care for patients and physicians by developing medicines with fundamentally new mechanisms of action. For more information, visit www.epizyme.com.
What are the dates of Epizyme's investor conferences in March 2022?
Epizyme will participate in the Cowen 42nd Annual Health Care Conference on March 8, 2022, and the Barclays Global Healthcare Conference on March 15, 2022.
Who will represent Epizyme at the Cowen 42nd Annual Health Care Conference?
Shefali Agarwal, Chief Medical Officer, will represent Epizyme at the Cowen 42nd Annual Health Care Conference.
What time is Epizyme's presentation at the Barclays Global Healthcare Conference?
Epizyme's presentation at the Barclays Global Healthcare Conference is scheduled for March 15, 2022, at 2:05 pm EST.
Where can I watch the webcasts of Epizyme's conference presentations?
The webcasts of Epizyme's conference presentations will be available on their investor section of the website and archived for 60 days.
